<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <actions>
      <actionTypeCounts>
        <considerationByHouse>1</considerationByHouse>
        <unionCalendarAssignment>1</unionCalendarAssignment>
        <motionToReconsiderResults>1</motionToReconsiderResults>
        <designationOfSpeakerProTempore>1</designationOfSpeakerProTempore>
        <finalPassageUnderSuspensionOfTheRulesResults>1</finalPassageUnderSuspensionOfTheRulesResults>
        <passedAgreedToInHouse>1</passedAgreedToInHouse>
        <actionStageOverride>3</actionStageOverride>
        <referredToCommittee>1</referredToCommittee>
        <billReferrals>1</billReferrals>
        <committeeReportOfABill>1</committeeReportOfABill>
        <placeholderTextForH>3</placeholderTextForH>
        <generalDebate>1</generalDebate>
        <reportedToHouse>1</reportedToHouse>
        <introducedInHouse>1</introducedInHouse>
        <motionMadeToSuspendTheRules>1</motionMadeToSuspendTheRules>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
      <actionByCounts>
        <senate>1</senate>
        <houseOfRepresentatives>19</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2016-05-12</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <type>Floor</type>
        <actionDate>2016-05-11</actionDate>
        <actionCode>H38310</actionCode>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee />
        <actionTime>16:41:33</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
      </item>
      <item>
        <type>Floor</type>
        <actionDate>2016-05-11</actionDate>
        <actionCode>H37300</actionCode>
        <links>
          <link>
            <name>H2254-2256</name>
            <url>https://www.congress.gov/congressional-record/volume-162/house-section/page/H2254-2256</url>
          </link>
        </links>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee />
        <actionTime>16:41:30</actionTime>
        <text>On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2254-2256)</text>
      </item>
      <item>
        <type>Floor</type>
        <actionDate>2016-05-11</actionDate>
        <actionCode>8000</actionCode>
        <links>
          <link>
            <name>H2254-2256</name>
            <url>https://www.congress.gov/congressional-record/volume-162/house-section/page/H2254-2256</url>
          </link>
        </links>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <actionTime>16:41:30</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H2254-2256)</text>
      </item>
      <item>
        <type>Floor</type>
        <actionDate>2016-05-11</actionDate>
        <actionCode>H8D000</actionCode>
        <links>
          <link>
            <name>H.R. 4976</name>
            <url>https://www.congress.gov/bill/114th-congress/house-bill/4976</url>
          </link>
        </links>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee />
        <actionTime>16:28:40</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4976.</text>
      </item>
      <item>
        <type>Floor</type>
        <actionDate>2016-05-11</actionDate>
        <actionCode>H30000</actionCode>
        <links>
          <link>
            <name>H2254-2256</name>
            <url>https://www.congress.gov/congressional-record/volume-162/house-section/page/H2254-2256</url>
          </link>
        </links>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee />
        <actionTime>16:28:38</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H2254-2256)</text>
      </item>
      <item>
        <type>Floor</type>
        <actionDate>2016-05-11</actionDate>
        <actionCode>H30300</actionCode>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee />
        <actionTime>16:28:21</actionTime>
        <text>Mr. Guthrie moved to suspend the rules and pass the bill.</text>
      </item>
      <item>
        <type>Calendars</type>
        <actionDate>2016-05-10</actionDate>
        <actionCode>H12410</actionCode>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee />
        <text>Placed on the Union Calendar, Calendar No. 431.</text>
      </item>
      <item>
        <type>Committee</type>
        <actionDate>2016-05-10</actionDate>
        <actionCode>H12200</actionCode>
        <links>
          <link>
            <name>H. Rept. 114-557</name>
            <url>https://www.congress.gov/congressional-report/114th-congress/house-report/557</url>
          </link>
        </links>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 114-557.</text>
      </item>
      <item>
        <type>Committee</type>
        <actionDate>2016-05-10</actionDate>
        <actionCode>5000</actionCode>
        <links>
          <link>
            <name>H. Rept. 114-557</name>
            <url>https://www.congress.gov/congressional-report/114th-congress/house-report/557</url>
          </link>
        </links>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 114-557.</text>
      </item>
      <item>
        <actionDate>2016-04-27</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Ordered to be Reported by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-27</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-26</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-25</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-20</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-20</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2016-04-18</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <type>IntroReferral</type>
        <actionDate>2016-04-18</actionDate>
        <actionCode>H11100</actionCode>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <text>Referred to the House Committee on Energy and Commerce.</text>
      </item>
      <item>
        <type>IntroReferral</type>
        <actionDate>2016-04-18</actionDate>
        <actionCode>Intro-H</actionCode>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <text>Introduced in House</text>
      </item>
      <item>
        <type>IntroReferral</type>
        <actionDate>2016-04-18</actionDate>
        <actionCode>1000</actionCode>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <text>Introduced in House</text>
      </item>
    </actions>
    <updateDate>2017-10-27T18:04:50Z</updateDate>
    <introducedDate>2016-04-18</introducedDate>
    <recordedVotes />
    <createDate>2016-04-19T05:11:32Z</createDate>
    <congress>114</congress>
    <sponsors>
      <item>
        <firstName>Sean</firstName>
        <lastName>Maloney</lastName>
        <state>NY</state>
        <bioguideId>M001185</bioguideId>
        <party>D</party>
        <identifiers>
          <lisID>2150</lisID>
          <gpoId />
          <bioguideId>M001185</bioguideId>
        </identifiers>
        <byRequestType />
        <middleName>Patrick</middleName>
        <fullName>Rep. Maloney, Sean Patrick [D-NY-18]</fullName>
        <district>18</district>
      </item>
    </sponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <titles>
      <item>
        <title>Opioid Review Modernization Act of 2016</title>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <titleType>Short Titles as Passed House</titleType>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <title>Opioid Review Modernization Act of 2016</title>
        <parentTitleType>Short Titles House of Representatives</parentTitleType>
        <titleType>Short Titles as Reported to House</titleType>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <title>Opioid Review Modernization Act of 2016</title>
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <title>To require the Commissioner of Food and Drugs to seek recommendations from an advisory committee of the Food and Drug Administration before approval of certain new drugs that are opioids without abuse-deterrent properties, and for other purposes.</title>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <title>Opioid Review Modernization Act of 2016</title>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <version>1.0.0</version>
    <cosponsors>
      <item>
        <bioguideId>L000567</bioguideId>
        <middleName />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Rep. Lance, Leonard [R-NJ-7]</fullName>
        <sponsorshipDate>2016-04-18</sponsorshipDate>
        <identifiers>
          <lisID>1936</lisID>
          <bioguideId>L000567</bioguideId>
          <gpoId>8049</gpoId>
        </identifiers>
        <sponsorshipWithdrawnDate />
        <party>R</party>
        <firstName>Leonard</firstName>
        <lastName>Lance</lastName>
        <state>NJ</state>
        <district>7</district>
      </item>
    </cosponsors>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. SEAN PATRICK MALONEY of New York:H.R. 4976.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H1802]</pre>]]></constitutionalAuthorityStatementText>
    <billType>HR</billType>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 114-557</citation>
      </committeeReport>
    </committeeReports>
    <notes />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Advisory bodies</name>
          </item>
          <item>
            <name>Child health</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Food and Drug Administration (FDA)</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <type>Standing</type>
          <chamber>Senate</chamber>
          <name>Health, Education, Labor, and Pensions Committee</name>
          <systemCode>sshr00</systemCode>
          <activities>
            <item>
              <date>2016-05-12T16:18:05Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
        <item>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <date>2016-04-20T19:29:19Z</date>
                  <name>Reported by</name>
                </item>
                <item>
                  <date>2016-04-20T19:28:54Z</date>
                  <name>Markup by</name>
                </item>
                <item>
                  <date>2016-04-18T19:28:47Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
              <name>Health Subcommittee</name>
            </item>
          </subcommittees>
          <type>Standing</type>
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
          <activities>
            <item>
              <date>2016-05-11T01:16:51Z</date>
              <name>Reported by</name>
            </item>
            <item>
              <date>2016-04-27T19:53:03Z</date>
              <name>Markup by</name>
            </item>
            <item>
              <date>2016-04-18T16:01:05Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <latestAction>
      <actionDate>2016-05-12</actionDate>
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <links />
    </latestAction>
    <relatedBills>
      <item>
        <number>5189</number>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>114</congress>
        <latestAction>
          <text>Referred to the Subcommittee on Military Personnel.</text>
          <actionDate>2016-06-07</actionDate>
        </latestAction>
        <type>HR</type>
        <latestTitle>Opioid Abuse Crisis Act of 2016</latestTitle>
      </item>
      <item>
        <number>524</number>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
          <item>
            <type>Related bill</type>
            <identifiedBy>House</identifiedBy>
          </item>
        </relationshipDetails>
        <congress>114</congress>
        <latestAction>
          <text>Became Public Law No: 114-198.</text>
          <actionDate>2016-07-22</actionDate>
        </latestAction>
        <type>S</type>
        <latestTitle>Comprehensive Addiction and Recovery Act of 2016</latestTitle>
      </item>
    </relatedBills>
    <laws />
    <originChamber>House</originChamber>
    <cboCostEstimates>
      <item>
        <title>H.R. 4976, Opioid Review Modernization Act of 2016</title>
        <pubDate>2016-05-10T17:12:32Z</pubDate>
        <url>https://www.cbo.gov/publication/51555</url>
      </item>
    </cboCostEstimates>
    <title>Opioid Review Modernization Act of 2016</title>
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2016-05-09T16:16:09Z</lastSummaryUpdateDate>
          <versionCode>00</versionCode>
          <actionDate>2016-04-18</actionDate>
          <text><![CDATA[<p><b>Opioid Review Modernization Act of 2016</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to refer new drug applications for opioids (drugs with effects similar to opium, such as certain pain medications) to an advisory committee before approval, unless the FDA finds that such a referral is scientifically unnecessary and not in the interest of protecting and promoting public health and the FDA notifies Congress of its rationale.</p> <p>The FDA must convene an advisory committee on labeling opioids for pediatric use before approving any such labeling.</p> <p>As part of its evaluation of the Extended-Release/Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy, the FDA must develop recommendations regarding education programs for prescribers of opioids.</p> The FDA must finalize the draft guidance entitled &quot;General Principals for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products.&quot;]]></text>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2016-04-18T04:00:00Z</updateDate>
          <name>Introduced in House</name>
        </item>
        <item>
          <lastSummaryUpdateDate>2016-06-13T14:43:58Z</lastSummaryUpdateDate>
          <versionCode>79</versionCode>
          <actionDate>2016-05-10</actionDate>
          <text><![CDATA[<p>(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)</p> <p><b>Opioid Review Modernization Act of 2016</b></p> <p>(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to refer new drug applications for opioids (drugs with effects similar to opium, such as certain pain medications) to an advisory committee before approval, unless the FDA finds that such a referral is scientifically unnecessary and not in the interest of protecting and promoting public health and the FDA notifies Congress of its rationale.</p> <p>The FDA must convene an advisory committee on labeling opioids for pediatric use before approving any such labeling.</p> <p>(Sec. 3) As part of its evaluation of the Extended-Release/Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy, the FDA must develop recommendations regarding education programs for prescribers of opioids.</p> (Sec. 4) The FDA must finalize the draft guidance entitled &quot;General Principals for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products.&quot;]]></text>
          <actionDesc>Reported to House without amendment</actionDesc>
          <updateDate>2016-05-10T14:25:46Z</updateDate>
          <name>Reported to House without amendment</name>
        </item>
        <item>
          <lastSummaryUpdateDate>2016-06-13T20:21:51Z</lastSummaryUpdateDate>
          <versionCode>81</versionCode>
          <actionDate>2016-05-11</actionDate>
          <text><![CDATA[<p>(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)</p> <p><b>Opioid Review Modernization Act of 2016</b></p> <p>(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to refer new drug applications for opioids (drugs with effects similar to opium, such as certain pain medications) to an advisory committee before approval, unless the FDA finds that such a referral is scientifically unnecessary and not in the interest of protecting and promoting public health and the FDA notifies Congress of its rationale.</p> <p>The FDA must convene an advisory committee on labeling opioids for pediatric use before approving any such labeling.</p> <p>(Sec. 3) As part of its evaluation of the Extended-Release/Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy, the FDA must develop recommendations regarding education programs for prescribers of opioids.</p> (Sec. 4) The FDA must finalize the draft guidance entitled &quot;General Principals for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products.&quot;]]></text>
          <actionDesc>Passed House without amendment</actionDesc>
          <updateDate>2016-05-11T13:33:00Z</updateDate>
          <name>Passed House without amendment</name>
        </item>
      </billSummaries>
    </summaries>
    <calendarNumbers>
      <item>
        <calendar>U00431</calendar>
        <number />
      </item>
    </calendarNumbers>
    <billNumber>4976</billNumber>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

